xin tong
Northwestern University
Evanston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Northwestern University
Evanston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Showa University
Shinagawa, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
George Washington University
Washington, D.C., United States
Review Editor
Cancer Molecular Targets and Therapeutics
Health Sciences University of Hokkaido
Tobetsu, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
School of Medicine, Tulane University
New Orleans, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Brown University
Providence, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Brown University
Providence, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National University of Colombia
Bogotá, Colombia
Review Editor
Cancer Molecular Targets and Therapeutics
AIMST University
Bedong, Malaysia
Review Editor
Cancer Molecular Targets and Therapeutics
Baylor Scott & White Research Institute (BSWRI)
Dallas, United States
Review Editor
Cancer Molecular Targets and Therapeutics
The Edward Via College of Osteopathic Medicine (VCOM)
Auburn, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Division of Hematology and Clinical Immunology, Department of Medicine, School of Medicine and Surgery, University of Padua
Padua, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Italian Institute of Technology (IIT)
Genova, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
St. Jude Children's Research Hospital
Memphis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Cancer Molecular Targets and Therapeutics
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics